Northern Trust Corp Celularity Inc Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.42 - $0.81 $158,706 - $306,076	-377,872 Reduced 73.21%	138,248 $73,000
Q1 2023 May 15, 2023	SELL	$0.56 - $1.15 $18,697 - $38,396	-33,388 Reduced 6.08%	516,120 $319,000
Q4 2022 Feb 13, 2023	SELL	$1.08 - $2.35 $11,877 - $25,845	-10,998 Reduced 1.96%	549,508 $708,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $194,026 - $1.94 Million	451,225 Added 412.9%	560,506 $1.29 Million
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $307,079 - $1.41 Million	109,281 New	109,281 $372,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.